Results 21 to 30 of about 1,023,691 (284)
Diabetic peripheral neuropathy
Abstract: Patients with diabetes mellitus may experience painful and nonpainful diabetic peripheral neuropathy (DPN). This article offers an overview of DPN and the clinical assessment and management of patients with DPN, as well as the nurse's role in supporting these patients.
Joyce K, Anastasi, Chloe, Klug
openaire +4 more sources
Neuropathy - gait changes in the diabetic foot [PDF]
Motor neuropathy in patients with diabetes can lead to weakness in the muscles of the foot and lower leg, which in turn can lead to characteristic changes to the structure of the foot, such as an altered arch profile.
McIntosh, Caroline, Newton, Veronica
core +3 more sources
Neuropathy - pain damage and the diabetic foot [PDF]
Neuropathy, or the impairment of nerve structures and function, is a common complication in diabetes and affects up to one-third of patients. The most common manifestation is the loss of pain sensation and this can lead to unrecognised trauma injuries ...
Newton, Veronica
core +5 more sources
Aims/Introduction Non‐alcoholic fatty liver disease and type 2 diabetes mellitus are closely related, and often occur simultaneously in patients. Type 2 diabetes increases the risk of diabetic peripheral neuropathy, resulting in intolerable pain and ...
Jinya Huang +9 more
doaj +1 more source
Diabetic peripheral neuropathy: A systematic review of Nigerian patients
Diabetes mellitus is associated with microvascular and macrovascular complications. Diabetic neuropathy is the most common long-term complication of diabetes.
Taoreed Azeez +2 more
doaj +1 more source
Background: Diabetic peripheral neuropathy remains asymptomatic until the late stages. Hence, a need exists for a reliable and sensitive biomarker for the early diagnosis of diabetic peripheral neuropathy.
Sangeetha Kandasamy +3 more
doaj +1 more source
Updates in diabetic peripheral neuropathy [PDF]
Diabetes has become one of the largest global health-care problems of the 21 st century. According to the Centers for Disease Control and Prevention, the population prevalence of diabetes in the US is approaching 10% and is increasing by 5% each year.
Juster-Switlyk, Kelsey, Smith, A. Gordon
openaire +2 more sources
THE RELATIONSHIP BETWEEN SERUM CALPROTECTIN AND PERIPHERAL NEUROPATHY IN A SAMPLE OF EGYPTIAN TYPE 2 DIABETIC PATIENTS [PDF]
Background: Plasma calprotectin is a persistent biomarker of insulin resistance (IR), gastroenteritis, and cardiovascular disease (CVD). Elevated plasma levels of calprotectin have been reported in a variety of chronic inflammatory conditions.
Ahmed Bahaa El Din +4 more
doaj +1 more source
Potential predictive biomarker for diabetic peripheral neuropathy: serum neuron-specific enolase
The early stages of diabetic peripheral neuropathy (DPN) are symptomless. A reliable dependable and sensitive biomarker is needed for the purpose of early identification of diabetic peripheral neuropathy.
Majeed Islam Fareed +3 more
doaj +1 more source
Diabetic peripheral polyneuropathy in the practice of a primary care physician
Diabetic peripheral sensorimotor neuropathy is one of the most common complications of diabetes mellitus. Diagnosis of diabetic peripheral neuropathy consists of symptom assessment and clinical neurologic examination using quantitative tests to assess ...
E. Yu. Komelyagina, M. B. Antsiferov
doaj +1 more source

